2024
Understanding chronic pain in Neurofibromatosis Type 1 using the Neurofibromatosis Pain Module (NFPM)
Buono F, Larkin K, Zempsky W, Grau L, Martin S. Understanding chronic pain in Neurofibromatosis Type 1 using the Neurofibromatosis Pain Module (NFPM). American Journal Of Medical Genetics Part A 2024, 194: e63541. PMID: 38234177, DOI: 10.1002/ajmg.a.63541.Peer-Reviewed Original ResearchNeurofibromatosis type 1Chronic painImpact of CPPain modulationPain regionsModerate pain severityType 1Autosomal dominant genetic disorderCross-sectional studyQuality of lifeDominant genetic disorderMedical providersPain severitySensitive clinical measureDaily functioningClinical measuresPainEffective treatmentGenetic disordersNeurofibromatosisClinical assessmentMultiple domainsAdultsQuantitative responseProviders
2013
Drug users in Hanoi, Vietnam: factors associated with membership in community-based drug user groups
Hayes-Larson E, Grau LE, Khoshnood K, Barbour R, Khuat OT, Heimer R. Drug users in Hanoi, Vietnam: factors associated with membership in community-based drug user groups. Harm Reduction Journal 2013, 10: 33. PMID: 24268108, PMCID: PMC4176489, DOI: 10.1186/1477-7517-10-33.Peer-Reviewed Original ResearchConceptsDrug user groupsResult of membershipDomains of knowledgeInjection-related harmsLongitudinal studyGreater historyDrug usePost-hoc evaluationMembershipLow statistical powerFurther longitudinal studiesQuality of lifeUser groupsFaceHigh levelsPeersMore attentionHealth issuesMultivariate modelBeingHarm reductionDrug usersKnowledge variablesHarmVariables